General Psychiatry and Psychology (Adult)
Showing 201-250 of 405 Results
-
Shelby Scott Lazarow, Psy.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Lazarow is a licensed psychologist who specializes in providing clinical care for individuals and couples dealing with acute and chronic medical conditions. She received her doctorate in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium and completed her clinical internship and postdoctoral fellowship at California Pacific Medical Center in the Health Psychology track. Dr. Lazarow is currently serving patients of the Neuropsychiatry Clinic at Stanford University's School of Medicine. In addition to providing individual and couples therapy, Dr. Lazarow has created multiple therapy groups specifically designed for individuals dealing with neurological conditions.
-
Laura C. Lazzeroni, Ph.D.
Professor (Research) of Psychiatry and Behavioral Sciences, Emerita
BioA key signatory of the Great Barrington Declaration against the Covid lockdowns,before publication on October 5, 2020.
-
Melanie Lean
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMelanie Lean, Clin.Psych.D. is a Californian licensed clinical psychologist, Clinical Assistant Professor, and assistant director of research in the INSPIRE early psychosis clinic, Stanford University School of Medicine. She provides Cognitive Behavioral Therapy for psychosis (CBTp) within the recovery oriented and trauma informed framework of the INSPIRE clinic. Dr Lean received her doctorate from University College London, UK and completed her postdoctoral fellowship at Stanford University. She is a mixed methods researcher, with over 15 years’ experience in mental health research, working across a range of settings with a focus on severe and enduring mental illness and ways to improve service provision for this population. She has specialized knowledge in self-management and peer support interventions for people with psychosis and has experience working alongside service user researchers in the evaluation and delivery of study interventions. Dr Lean is also trained in psychedelic assisted therapy and works on a range of clinical trials investigating psilocybin for treatment resistant depression.
-
Grace Eun Lee, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGrace Lee, Ph.D. is a Clinical Assistant Professor and a CA Licensed Clinical Psychologist in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Lee specializes in evidence-based, trauma-informed, and culturally-responsive care for individuals presenting with psychosis and post-traumatic stress. She is currently providing Cognitive Behavioral Therapy for Psychosis (CBTp), Cognitive Processing Therapy (CPT), Prolonged Exposure Therapy (PE), Narrative Exposure Therapy (NET), and Written Exposure Therapy (WET) within the INSPIRE Clinic and PTSD Clinic. She also leads national and international trainings in CBTp to providers supporting individuals with psychosis.
-
Jonathan Lee (@ jonlee112)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioClincal:
Dr. Jonathan Lee, MD, PhD (@ jonlee112) is a Clinical Assistant Professor of Psychiatry and Behavioral Sciences at the Depression Clinic of Stanford University where he founded the "Am I Good? Examining life through the lenses of Philosophical Skepticism, Moral Philosophy, and Existentialism" philosophical psychotherapy group.
Jonathan Lee, MD, PhD (@ jonlee112) practices psychiatry, including psychotherapy, at Stanford University. He utilizes psychopharmacology alongside a particular approach to philosophical therapy, which he has termed ‘Decompositionism‘. Decompositionism is an approach to philosophical psychotherapy, developed by Jonathan Lee, MD, PhD (@ jonlee112), which is informed by knowledge from neuroscience, psychology, and philosophy…
Epistemology, Skepticism
Metaphysics, Ontology
Philosophy of Language
Philosophy of Mind
Moral Philosophy, Metaethics
Existentialism
…Decompositionism revolves around the use of analytical approaches aimed at decomposing cognitive concepts (words, phrases, thoughts, ideas, emotions, beliefs, etc) into their most fundamental components or features. Jonathan Lee, MD, PhD (@ jonlee112) designed Decompositionism to examine fundamental questions such as:
What is truth? What is reality? How do we know what we know? How do our brains/minds learn?
What actually exists in the universe?
What do we mean by the words, phrases, and concepts that we invoke in daily life?
What is right vs. wrong? What are our moral obligations?
What is good vs. bad?
What is the meaning of life? What is the point of life? What is the purpose of life?
Does free will exist?
Research:
His research focuses on the causes and consequences of, as well as solutions to, rising skepticism and distrust in sources of expert information (e.g., science, health). He has a special interest in exploring skepticism and persuasion at the intersection of health and politics, which includes studying phenomena such as the politicization of science and health, political polarization, filter bubbles/echo chambers, the emerging post-truth world, and information warfare. It also includes seeking heteorgeneity in the findings across particular demographics at high socioeconomic and health risk. He draws on theories and methods from his uniquely interdisciplinary set of educational, research, and professional experiences, including those from experimental and behavioral economics, political science, psychology, philosophy, and machine learning. He is currently using machine learning-based text analytics to explore how trust/distrust in sources of expert information is discussed on traditional and social media -- followed by the use of online randomized controlled survey experiments to test the causal effects of particular persuasion strategies on perceptions of trust/distrust, as well as other important behavioral outcomes of interest. -
Anna Lembke, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
BioDr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, and a diplomate of the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine.
In 2016, she published "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives.
Her latest book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller and has been translated into 30 languages. It combines the neuroscience of addiction with the wisdom of recovery to explore the problem of compulsive overconsumption in a dopamine-overloaded world. -
Eric Lin
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioEric Lin, MD, is a Clinical Assistant Professor (Affiliated) of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and an addiction psychiatrist at VA Palo Alto. His academic work focuses on artificial intelligence, large language models, machine learning, and psychiatry, with particular interest in the clinical evaluation, safety, and governance of AI systems used in mental health care and related psychological contexts.
Dr. Lin studies how AI systems should be assessed when they interact with patients, clinicians, or psychologically vulnerable users. His work addresses the limitations of benchmark-driven evaluation and the need for clinically meaningful approaches to AI evaluation that incorporate psychiatric expertise, real-world clinical complexity, and post-deployment risk. His broader interests include psychopathology, personality assessment, psychoanalytic and psychodynamic models of mind, and the translation of complex clinical judgment into rigorous evaluation frameworks for emerging technologies.
Dr. Lin completed psychiatry residency at Yale University, where he trained in the Neuroscience Research Training Program, and later completed a medical informatics fellowship through VA Boston, with research at Harvard Medical School/McLean Hospital on computational and digital approaches to psychiatric phenotyping. He is board certified in psychiatry and clinical informatics. His clinical and teaching work in addiction psychiatry grounds his interest in psychiatric complexity, risk assessment, care navigation, and pragmatic implementation of AI tools in health care. He is interested in collaborations across psychiatry, computer science, human-centered AI, health policy, digital mental health, and responsible technology development. -
Stacy Lin
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Stacy Lin is a licensed psychologist in the Department of Psychiatry and Behavioral Sciences who provides culturally-informed psychotherapy for the treatment of emotion dysregulation, eating disorders, and trauma. Dr. Lin has specialized training in comprehensive Dialectical Behavior Therapy and Cognitive Behavioral Therapy. She is broadly interested in issues of diversity and inclusion in clinical, training, and professional settings. Her research has examined cultural factors affecting disordered eating and body image in racial/ethnic minorities.
-
Anne Juliana Lockman
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Lockman is Adjunct Clinical Associate Professor of Neuropsychiatry in the Department of Psychiatry & Behavioral Sciences at Stanford. She directs the Functional Neurologic Disorder (FND) Track at La Selva in Palo Alto, within their state-of-the-art residential and partial hospitalization programs. She completed residencies in both Neurology at the University of Virginia and Psychiatry at Stanford Hospital & Clinics. Her clinical activities include providing pharmacologic and behavioral care for clients with psychiatric and behavioral conditions in the context of neurological illness, including epilepsy, stroke, movement disorders and others. Professional goals include the advancement of clinical care, research and access for clients suffering from neuropsychiatric conditions, including FND and related disorders.
-
Kristine Luce
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Luce is a Psychologist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. She received her doctorate in Clinical Psychology from Kent State University. She completed a pre-doctoral internship at the Seattle Veterans Hospital and a post-doctoral research fellowship at Stanford University in the Department of Psychiatry and Behavioral Sciences. Dr. Luce has clinical and research experience with eating-related disorders and is the Co-Director of the Stanford Adult Eating Disorders Program. In addition, Dr. Luce treats anxiety and mood disorders and has specialized clinical training in Cognitive Behavioral Therapy and Dialectical Behavioral Therapy.
-
Julie Lutz, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Julie Lutz is a licensed clinical psychologist with specialty training in geropsychology/aging and suicide prevention. She received her PhD from West Virginia University, completed her predoctoral internship with an emphasis in geropsychology at the VA Palo Alto Health Care System, and completed a T32 postdoctoral clinical research fellowship in suicide prevention at the University of Rochester Medical Center in New York. She worked in clinical research on suicide prevention among older Veterans at the VA Palo Alto Health Care System following postdoctoral fellowship. Her research and clinical work both focus on evidence-based behavioral interventions to address mental health, social connection, and coping with chronic health and functioning issues to reduce risk in later life.
-
David Lyons
Professor (Research) of Psychiatry & Behavioral Sciences (General Psychiatry and Psychology-Adult), Emeritus
Current Research and Scholarly InterestsBehavioral neuroscience
-
Maryam S. Makowski, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMaryam S. Makowski, PhD, FACN, CNS, NBC-HWC, is a Clinical Associate Professor in the Stanford University Department of Psychiatry and Behavioral Sciences and the Associate Director of Scholarship and Health Promotion for Stanford Medicine’s WellMD & WellPhD program. As a medical nutrition scientist, Certified Nutrition Specialist, and National Board Certified Health and Wellness Coach, Dr. Makowski provides nutrition consultations and well-being coaching to Stanford School of Medicine faculty, as well as Stanford Medicine residents and fellows through the WellConnect Program. She also provides mental health and nutrition coaching to patients at the Lifestyle Psychiatry Clinic as a Health and Wellness Coach in the Department of Psychiatry and Behavioral Sciences.
Dr. Makowski's research focuses on identifying nutritional strategies to minimize physician fatigue, stress, and sleep-related impairment. In her coaching, she employs evidence-based and personalized strategies to optimize the well-being and performance of her clients. In recognition of her contributions, she received the 2024 Annual Chairman's Award for Clinical Innovation and Service in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
She earned her master's and doctoral degrees in clinical nutrition, nutritional epidemiology, and medical science from the University of Toronto. Prior to joining Stanford, Dr. Makowski worked as a scientific associate at Toronto General Hospital–University Health Network and served as an advisor to Air Canada Rouge pilots and cabin crew on fatigue management. Throughout her career, she has authored highly cited scientific papers related to nutrition and well-being, making significant contributions to the field. She has delivered over 100 lectures, grand rounds, seminars, and webinars to thousands of physicians and physician trainees worldwide. -
Alan G. Maloney
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioPsychiatrist and Jungian Analyst in private practice in San Francisco and Palo Alto.
-
Rachel Manber, PhD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsRecent and current projects include
Treatment of insomnia during pregnancy
Treatment of insomnia comorbid with sleep apnea
Use of digital interventions for insomnia among middle age and older adults
Mobile intervention for insomnia among those with alcohol use -
Jessie Markovits, MD
Clinical Associate Professor, Medicine
Clinical Associate Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsHypnosis for perioperative symptom management in elective orthopedic surgery.
-
Brittany Elizabeth Matheson, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBrittany Matheson, PhD, is a clinical associate professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford (LPCH)/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the director of psychological services for the LPCH adolescent metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.
-
Mohamad Matout, MD, MSc
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mohamad Matout is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. He is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Matout specializes in using brain stimulation therapies to treat mental illnesses and neurological disorders that do not respond to standard treatments. These therapies include deep brain stimulation (DBS), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). He serves as the attending psychiatrist for the Youth TMS Clinic at Stanford Health Care, providing transcranial magnetic stimulation for adolescents with treatment-resistant mood disorders. Dr. Matout also uses avatar therapy, an investigational treatment for psychosis that involves using a digital avatar to represent the voices a patient hears.
Dr. Matout’s research centers on brain health as a unifying framework for understanding psychiatric illness across the lifespan. Using a statistical modeling technique called psychometric network analysis, he maps how psychiatric symptoms mutually reinforce or suppress one another. This method reveals the structure of mental illness beyond traditional diagnostic categories. Dr. Matout developed the approach through his graduate work on brain health in HIV and post-COVID syndrome. He now applies it to neuromodulation (changing nerve signals for treatment) and other novel interventions.
Dr. Matout’s two primary lines of research are TMS for adolescents and avatar therapy. He also contributes to a broader range of neuromodulation studies through collaboration with the Brain Stimulation Lab at Stanford University School of Medicine. Beyond his clinical and research work, Dr. Matout is co-founder of AVAtalk Technologies Inc., a mental health technology startup focused on avatar-based therapeutic solutions.
Dr. Matout has authored peer-reviewed publications in Social Psychiatry and Psychiatric Epidemiology, Quality of Life Research, and CEN Case Reports. He has also contributed chapters to Current Medical Diagnosis & Treatment 2027 and Katzung & Trevor's Basic & Clinical Pharmacology (17th ed., McGraw-Hill, in press).
Dr. Matout is a member of the American Neuropsychiatric Association (ANPA) and the Brain Stimulation Society (BraSS), where he serves as assistant treasurer. -
Carmen McLean
Clinical Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioCarmen McLean, PhD, is a clinical psychologist and researcher with the Dissemination and Training Division of the National Center for PTSD at the Palo Alto VA Health Care System. Dr. McLean’s research focuses on increasing the implementation and reach of evidence-based treatments for posttraumatic stress disorder (PTSD).
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Kelli Moran-Miller, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Kelli Moran-Miller joined Stanford in Psychiatry & Behavioral Sciences in 2015. She is a licensed psychologist specializing in athlete mental health and sport and performance psychology. She also is a Certified Mental Performance Consultant with the Association of Applied Sport Psychology and a member of the US Olympic Committee registry. In her current role with Stanford Athletics (DAPER), she provides clinical and performance psychology services for varsity student-athletes, coaches, staff, and varsity sport teams. Prior to Stanford, she was the Director of Counseling and Sport Psychology - Athletics at the University of Iowa.
-
Trishna Narula, MD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Narula is currently serving patients at Stanford's centerspace clinic, where she is also working to lead and launch a new South Asian program.
